Journey Medical Corporation (DERM)

NCM – Real Time Price. Currency in USD

6.33

+0.01 (0.16%)

Market open: Aug 12, 2026, 10:12 AM EDT

6.32

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 4:10 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

05.08.2026

Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026

SCOTTSDALE, Ariz., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company primarily focused on developing, selling and marketing U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced the Company will release its second quarter 2026 financial results after the U.S. financial markets close on Wednesday, August 12, 2026.

Videos

No Data

There is no data to display

Journey Medical Corporation (DERM)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Journey Medical Corporation (DERM)

Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026

Videos

No Data

Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026

Videos

No Data

Search stocks

Journey Medical Corporation (DERM)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Journey Medical Corporation (DERM)

Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026

Videos

No Data

Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026

Videos

No Data